About Strate Skin Sciences
Strate Skin Sciences is a company based in Horsham (United States) founded in 1989. The company has 106 employees. Strate Skin Sciences operates in a competitive market with competitors including Cutera, Lumenis, Cartessa Aesthetics, Solta and InMode Aesthetic Solutions, among others.
- Headquarter Horsham, United States
- Employees 106
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website strataskinsciences.com
- Legal Name Strata Skin Sciences, Inc.
- Annual Revenue$33.56 M (USD)0.61as on Dec 31, 2024
- Net Profit-$10.09 M (USD)6.87as on Dec 31, 2024
- EBITDA-$87 K (USD)79.19as on Dec 31, 2024
- Latest Funding Round$17M (USD), Post-IPO
Apr 2018
- InvestorsAccelmed
& 3 more
- Employee Count106
Funding Insights of Strate Skin Sciences
- Total Rounds 2
- Last Round Post-IPO — $17M
- First Round $27.3M
(Jul 2014)
- Investors Count 4
All 2 funding rounds of Strate Skin Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2018 | $17M | Post-IPO | – | – | |
| Jul 2014 | $27.3M | Post-IPO | – | – | – |
4 investors in total: 3 institutional and 1 angel.
Investors in Strate Skin Sciences
Strate Skin Sciences has secured backing from 4 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Accelmed, Dolev Rafaeli and Broadfin Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | accelmed.com | - | |
Investment opportunities in healthcare are managed by Broadfin Capital. | 2005 | broadfin.com | Melville, United States | |
- | – | sabbymanagement.tcc.mode | - | |
DR Dolev Rafaeli | - | – | unknown_5457b21715b241bc8 | - |
Investor details for Strate Skin Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Strate Skin Sciences
15 people are tracked at Strate Skin Sciences (6 in leadership, 9 in team); the tracked headcount is 106.
| Name | Role | Group |
|---|---|---|
Robert J Moccia | CEO & President | Leadership |
Robert (Bob) Moccia | CEO | Leadership |
Bassel Malo | Director Of Operations | Leadership |
Shmuel Gov | Chief Operating Officer | Leadership |
Aman K. | Vice President Marketing And Business Growth | Leadership |
John Gillings | VP Finance | Leadership |
Derrick Broomfield | Manufacturing Technician | Team |
Keith Glatfelter | Field Service Operation Manager | Team |
Isabelle Rospert | Territory Manager | Team |
Blake Peterson | Sales Associate | Team |
Ej Ciaccio | Territory Sales Manager | Team |
Uriel Garcia | Territory Sales Manager | Team |
Daniel Hastings | Territory Manager | Team |
Halie Rion | Senior Clinical Specialist | Team |
Rich McEvoy | Field Service Manager | Team |
Complete people profiles for Strate Skin Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Strate Skin Sciences
Strate Skin Sciences is a publicly listed company on the NASDAQ with ticker symbol SSKN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date28 Oct 2005
- Listed onNASDAQ: SSKN
- Listed entityStrata Skin Sciences, Inc.
- Exchange sectorHealth technology
- ISINUS86272A3059
- Share price$0.19 (-39.99% on the day) · 2026-02-19
- Market capitalisation$1.1M
- EPS (diluted, trailing year)$-2.62
- Volume (last session)4,047,664
- Analyst consensusStrong buy
Financials of Strate Skin Sciences
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2024 | $33.6M | -$10.1M | -$87,000 |
| 2023 | $33.4M | -$10.8M | -$418,000 |
| 2022 | $36.2M | -$5.5M | $1.0M |
| 2021 | $30.0M | -$2.7M | -$316,000 |
| 2020 | $23.1M | -$4.4M | -$165,000 |
Detailed financial statements for Strate Skin Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Strate Skin Sciences
4 dated milestones of Strate Skin Sciences across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Strate Skin Sciences is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $27.3M.
- Funding Latest funding round, Post-IPO, of $17.0M.
Competitors of Strate Skin Sciences
Strate Skin Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cutera, Lumenis, Cartessa Aesthetics, Solta and InMode Aesthetic Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cutera.com | 1998 | Brisbane, United States | – | 540 | Energy-based aesthetic devices are developed for medical treatments. | |
| lumenis.com | 1973 | Yokneam Illit, Israel | – | – | Minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets | |
| cartessaaesthetics.com | 2017 | New York, United States | $60M | 129 | Aesthetic medical devices | |
| solta.com | 1995 | Hayward, United States | – | 6,355 | Energy-based aesthetic medical devices are designed and marketed. | |
| inmodemd.com | 2008 | Lake Forest, United States | – | 171 | Develops a portfolio of aesthetic solutions | |
| medshift.com | 2015 | Charlotte, United States | $116M | – | Medical practice management services | |
| almalasers.com | 1980 | Buffalo Grove, United States | – | 48 | Portfolio of optical, radiofrequency and ultrasound devices for aesthetic & medical applications | |
| syneron-candela.com | 1970 | Marlborough, United States | – | – | Candela Medical is engaged in developing aesthetic laser devices. |
Detailed competitors of Strate Skin Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Strate Skin Sciences
The website of Strate Skin Sciences (strataskinsciences.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 29.3% vs previous month
Latest news on Strate Skin Sciences
Complete news archive for Strate Skin Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Strate Skin Sciences
10 companies that operate in the same segment as Strate Skin Sciences (Dermatology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Developer of drugs for treating dermatology diseases | 1908 | Copenhagen, Denmark | USD 560.38 M | – | – | |
Skincare, beauty, and wellness services provided by VLCC across multiple countries. | 1989 | Delhi, Delhi, India | – | – | – | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Immunotherapeutic solutions for dermatological conditions are developed. | 2016 | Westlake Village, California, United States | USD 94.5 M | USD 376.07 M | 342 | |
Targeted small molecules are developed for oncology treatments. | 2010 | Singapore, Singapore | USD 100 M | – | – | |
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. | 2014 | Pune, Maharashtra, India | USD 25.97 M | USD 18.15 M | 508 | |
Novel dermatologic therapies are developed for skin conditions. | 2012 | Malvern, Pennsylvania, United States | USD 82 M | USD 7.83 M | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Strate Skin Sciences
Strate Skin Sciences was founded in 1989 and raised its 1st funding round 25 years after it was founded.
Strate Skin Sciences is headquartered in Horsham, United States. It is registered at Horsham, Pennsylvania, United States.
Robert J Moccia is the current CEO of Strate Skin Sciences.
Strate Skin Sciences has 106 employees.
Annual revenue of Strate Skin Sciences is $33.56M as on Dec 31, 2024.
Strate Skin Sciences was founded in 1989 and is based in Horsham, United States, within the medical devices sector focused on dermatology. Ultraviolet and excimer laser technologies are utilized in the Xtrac and Vtrac devices to address psoriasis, vitiligo, and similar conditions. The MelaFind imaging system is also provided for data analysis to inform dermatologists decisions on biopsying irregular pigmented moles.
Strate Skin Sciences's top competitors include Lumenis, Cartessa Aesthetics and Cutera.
Yes, Strate Skin Sciences is publicly traded on NASDAQ under the ticker symbol SSKN.
Strate Skin Sciences has 4 investors. Key investors include Accelmed, Dolev Rafaeli, Broadfin Capital, and Sabby Management.